Pomerantz LLP filed a securities class action Tuesday in California Northern District Court against AcelRx Pharmaceuticals, its CEO and its CFO. The complaint accuses the defendants of making misleading claims regarding the efficacy of AcelRx’s Dsuvia pain medication, and potential risks in taking it. Counsel have not yet appeared for the defendants. The case is 3:21-cv-04353, Sneed Jr. v. AcelRx Pharmaceuticals, Inc. et al.
This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector.